340 related articles for article (PubMed ID: 8396016)
21. Ontogeny of insulin-like growth factor I and insulin receptor kinase activity in rat liver.
Menon RK; Chernausek SD; Sperling MA
J Dev Physiol; 1991 Aug; 16(2):87-97. PubMed ID: 1664842
[TBL] [Abstract][Full Text] [Related]
22. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.
Zahradka P; Litchie B; Storie B; Helwer G
Endocrinology; 2004 Jun; 145(6):2978-87. PubMed ID: 14976148
[TBL] [Abstract][Full Text] [Related]
23. Thyrotropin regulates autophosphorylation and kinase activity in both the insulin and the insulin-like growth factor-I receptors in FRTL5 cells.
Condorelli G; Formisano P; Miele C; Beguinot F
Endocrinology; 1992 Mar; 130(3):1615-25. PubMed ID: 1311244
[TBL] [Abstract][Full Text] [Related]
24. A developmentally regulated form of insulin-like growth factor receptor beta-subunit in C2 myoblasts exhibiting altered requirements for differentiation.
Barenton B; Domeyne A; Garandel V; Garofalo RS
Endocrinology; 1993 Aug; 133(2):651-60. PubMed ID: 8344204
[TBL] [Abstract][Full Text] [Related]
25. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
[TBL] [Abstract][Full Text] [Related]
26. Expression, action, and steroidal regulation of insulin-like growth factor-I (IGF-I) and IGF-I receptor in the rat corpus luteum: their differential role in the two cell populations forming the corpus luteum.
Parmer TG; Roberts CT; LeRoith D; Adashi EY; Khan I; Solan N; Nelson S; Zilberstein M; Gibori G
Endocrinology; 1991 Dec; 129(6):2924-32. PubMed ID: 1659518
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases.
Torres M; Hall FL; O'Neill K
J Immunol; 1993 Feb; 150(4):1563-77. PubMed ID: 7679431
[TBL] [Abstract][Full Text] [Related]
28. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
[TBL] [Abstract][Full Text] [Related]
29. IGF-I- and EGF-dependent DNA synthesis of porcine myoblasts is influenced by the dietary isoflavones genistein and daidzein.
Mau M; Kalbe C; Wollenhaupt K; Nürnberg G; Rehfeldt C
Domest Anim Endocrinol; 2008 Oct; 35(3):281-9. PubMed ID: 18635334
[TBL] [Abstract][Full Text] [Related]
30. Abundant insulin-like growth factor-1 (IGF-1) receptor binding in fish skeletal muscle.
Párrizas M; Plisetskaya EM; Planas J; Gutiérrez J
Gen Comp Endocrinol; 1995 Apr; 98(1):16-25. PubMed ID: 7781961
[TBL] [Abstract][Full Text] [Related]
31. Oxytocin and progesterone release from bovine corpus luteal cells in culture: effects of insulin-like growth factor I, insulin, and prostaglandins.
McArdle CA; Holtorf AP
Endocrinology; 1989 Mar; 124(3):1278-86. PubMed ID: 2645114
[TBL] [Abstract][Full Text] [Related]
32. Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth muscle cells.
Rao GN; Delafontaine P; Runge MS
J Biol Chem; 1995 Nov; 270(46):27871-5. PubMed ID: 7499260
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the juxtamembrane region of the insulin receptor impair activation of phosphatidylinositol 3-kinase by insulin.
Kapeller R; Chen KS; Yoakim M; Schaffhausen BS; Backer J; White MF; Cantley LC; Ruderman NB
Mol Endocrinol; 1991 Jun; 5(6):769-77. PubMed ID: 1656240
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-1-mediated association of p85 phosphatidylinositol 3-kinase with pp 185: requirement of SH2 domains for in vivo interaction.
Altschuler D; Yamamoto K; Lapetina EG
Mol Endocrinol; 1994 Sep; 8(9):1139-46. PubMed ID: 7838146
[TBL] [Abstract][Full Text] [Related]
35. Antiinsulin receptor autoantibodies induce insulin receptors to constitutively associate with insulin receptor substrate-1 and -2 and cause severe cell resistance to both insulin and insulin-like growth factor I.
Auclair M; Vigouroux C; Desbois-Mouthon C; Deibener J; Kaminski P; Lascols O; Cherqui G; Capeau J; Caron M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3197-206. PubMed ID: 10487687
[TBL] [Abstract][Full Text] [Related]
36. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
Guvakova MA; Surmacz E
Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
38. Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-I receptor abolishes autophosphorylation but does not eliminate biologic function.
Blakesley VA; Kato H; Roberts CT; LeRoith D
J Biol Chem; 1995 Feb; 270(6):2764-9. PubMed ID: 7852347
[TBL] [Abstract][Full Text] [Related]
39. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the in situ tyrosine kinase activity of mutant insulin receptors lacking tyrosine autophosphorylation sites 1162 and 1163.
Yonezawa K; Roth RA
Mol Endocrinol; 1991 Feb; 5(2):194-200. PubMed ID: 1710030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
